These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38872257)

  • 1. The neural substrates of social cognition deficits in newly diagnosed multiple sclerosis patients.
    Ziccardi S; Genova H; Colato E; Guandalini M; Tamanti A; Calabrese M
    Ann Clin Transl Neurol; 2024 Jul; 11(7):1798-1808. PubMed ID: 38872257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment.
    Pitteri M; Genova H; Lengenfelder J; DeLuca J; Ziccardi S; Rossi V; Calabrese M
    Mult Scler Relat Disord; 2019 Apr; 29():118-123. PubMed ID: 30710839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social Cognition Abilities in Patients With Different Multiple Sclerosis Subtypes.
    Henry A; Tourbah A; Chaunu MP; Bakchine S; Montreuil M
    J Int Neuropsychol Soc; 2017 Sep; 23(8):653-664. PubMed ID: 28656885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is impairment of facial emotion recognition independent of cognitive dysfunction in multiple sclerosis?
    Sever Aktuna YS; Koskderelioglu A; Eskut N; Aktuna A
    Neurol Sci; 2024 Jun; 45(6):2791-2800. PubMed ID: 38246940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of deep grey matter volume on cognition in multiple sclerosis.
    Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
    Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
    Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
    Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain microstructure is linked to cognitive fatigue in early multiple sclerosis.
    Guillemin C; Vandeleene N; Charonitis M; Requier F; Delrue G; Lommers E; Maquet P; Phillips C; Collette F
    J Neurol; 2024 Jun; 271(6):3537-3545. PubMed ID: 38538776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis.
    Cruz-Gomez ÁJ; Forero L; Lozano-Soto E; Cano-Cano F; Sanmartino F; Rashid-López R; Paz-Expósito J; Gómez Ramirez JD; Espinosa-Rosso R; González-Rosa JJ
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34465616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.
    Stellmann JP; Cetin H; Young KL; Hodecker S; Pöttgen J; Bittersohl D; Hassenstein A; Oberwahrenbrock T; Heesen C; Siemonsen S
    Brain Behav; 2017 Feb; 7(2):e00614. PubMed ID: 28239524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
    Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
    Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Recruitment During Executive Control Processing in Cognitively Preserved Patients With Pediatric-Onset MS.
    Barlow-Krelina E; Turner GR; Akbar N; Banwell B; Lysenko M; Yeh EA; Narayanan S; Collins DL; Aubert-Broche B; Till C
    J Int Neuropsychol Soc; 2019 Apr; 25(4):432-442. PubMed ID: 30813973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empathy in multiple sclerosis--Correlates with cognitive, psychological and occupational functioning.
    van der Hiele K; van Egmond EEA; Jongen PJ; van der Klink JJL; Beenakker EAC; van Eijk JJJ; Frequin STFM; Hoitsma E; Mostert JP; Verhagen WIM; van Gorp DAM; Middelkoop HAM; Visser LH
    Mult Scler Relat Disord; 2020 Jun; 41():102036. PubMed ID: 32169828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
    D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.
    Kania K; Pawlak MA; Forycka M; Wiłkość-Dębczyńska M; Michalak S; Łukaszewska A; Wyciszkiewicz A; Wypych A; Serafin Z; Marcinkowska J; Kozubski W; Kalinowska-Łyszczarz A
    Neurol Neurochir Pol; 2024; 58(2):176-184. PubMed ID: 38324117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.